Case Studies > Alphazyme Uses Qualio to Produce Molecular Enzymes at Scale for Biotech Companies

Alphazyme Uses Qualio to Produce Molecular Enzymes at Scale for Biotech Companies

Company Size

11-200

Region

America

Country

United States

Product

Qualio

Tech Stack

eQMS

Implementation Scale

Enterprise-wide Deployment

Impact Metrics

Customer Satisfaction
Innovation Output
Productivity Improvements

Technology Category

Application Infrastructure & Middleware - Data Exchange & Integration
Functional Applications - Enterprise Resource Planning Systems (ERP)

Applicable Functions

Business Operation
Quality Assurance

Use Cases

Process Control & Optimization
Regulatory Compliance Monitoring
Remote Collaboration

Services

System Integration
Training

About The Customer

Alphazyme is a biotechnology manufacturer headquartered in Jupiter, Florida that produces custom enzymes used by large-scale biotech companies to read, write, and edit DNA molecules. Founded in 2018 by CEO Christopher Benoit—a serial entrepreneur and expert in the enzyme development and production space—Alphazyme has grown steadily over the last 18 months as it helps biotech firms accelerate cutting-edge applications in DNA literacy technologies. The company has a strong focus on innovation and quality, aiming to provide high-quality enzymes that meet stringent regulatory standards.

The Challenge

In 2005, Benoit founded a life sciences company called Enzymatics, which has since been acquired by QIAGEN. After an early customer sent over an 18-page supplier evaluation form and asked for a site visit to further explore their products and processes, Benoit realized the company needed to rapidly implement a robust quality management system. At the time, electronic QMS systems were rare, not user-friendly, and costly, so the Enzymatics team established a paper-based system—a decision that turned into a learning experience. Seeking to avoid a similar problem in his new venture, the Alphazyme business plan called for a paperless, ISO 13845-compliant quality system architecture from the get-go.

The Solution

Right after Stephana Petrino was hired as the Vice President of Quality at Alphazyme, she was tasked with finding an eQMS that met these requirements. Because the young company needed to operate with agility, the right system would also need to be flexible. Petrino examined roughly 15 solutions and had sales discussions with eight vendors. After thoroughly assessing the options, Alphazyme selected the Qualio product and embarked on a process of building its quality system inside the system - from the ground up. “We needed something that was user-friendly, easy to onboard new team members, and easy to get up and running,” Petrino says. “Qualio has surpassed our expectations on those metrics.”

Operational Impact

Streamlined, Rapid Product Development: Alphazyme has been able to bring numerous products and development processes online rapidly, thanks to Qualio.
Streamlined Collaboration: Qualio has enabled Alphazyme to streamline collaboration across the organization. Currently, all categories of team members—from C-level executives to scientists, quality engineers, and more—use Qualio to document, review, and approve their work.
Improved Productivity: Qualio’s intuitive design has helped the Alphazyme team to work more productively together. The system is easy for people to grasp and start navigating immediately upon hire.
Future-Proofing Processes: Qualio is more than just a stagnant product. It’s a robust solution that they are able to influence with their feedback and suggestions, ensuring it grows alongside them.
Customer Validation: Qualio has also impressed Alphazyme’s clients. A publicly traded company conducted a “light” audit of Alphazyme’s facilities and was impressed by the role Qualio played in the Company’s operations.

Quantitative Benefit